CHICAGO, Oct. 13, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Genome Editing Market / Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End User (Pharma, Biotechnology, Science) – Global Forecast to 2026”The global genome editing market is forecast to grow from USD 5.1 billion in 2021 to USD 11.7 billion by 2026, at a CAGR of 18.2% between 2021 and 2026.
Browse the detailed table of contents on “Genome Editing Market / Genome Engineering Market“
147 – tables
48 – numbers
208 pages
Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000
Scope of the report:
| report coverage | details |
| market size | $11.7 billion by 2026 |
| CAGR | 18.2% |
| Historical data | 2019-2026 |
| base year | 2020 |
| forecast period | 2021-2026 |
| Forecast Units | Value (Billion USD) |
| report coverage | Sales Forecast, Competitive Landscape, Growth Factors and Trends |
| Covered Segments | By product and service, by technology, by application, by geography |
| Regions Covered | North America, Europe, Asia Pacific, LAME and Rest of World |
| Profiled key companies/vendors | Thermo Fisher Scientific Inc. (USA) | Merck KGaA (Germany)| GenScript (China) |
| Important market opportunities | Extensive use of genome editing in personalized medicine. |
| Important market drivers | Increase in government funding and increase in the number of genomics projects. |
Developments in this field have led to significant improvements in genome editing capabilities that have enabled the modification of gene sequences of interest in a variety of cell types and model organisms. Genome engineering, formerly used by large research organizations such as academic and government research centers, has now become a potentially transformative diagnostic tool, particularly for oncology studies. This shift from academics to clinical and diagnostic laboratories is primarily driven by rapid improvements in gene editing technologies.
Based on product &…
